CMV Titers in Pregnant Patients with Prior Exposure
No, routine CMV serology testing is not recommended for pregnant patients with prior CMV exposure in the absence of specific clinical indications.
When CMV Testing IS Indicated
CMV IgG and IgM titers should be ordered in pregnant patients with prior exposure only in the following specific scenarios:
Clinical Indications for Testing
Fetal ultrasound abnormalities suggestive of congenital infection, particularly:
Maternal symptoms suggestive of acute CMV infection (influenza-like illness during pregnancy) 4
The Rationale Against Routine Screening
Routine screening of all pregnant women for CMV is not recommended 3, 4. This applies even to women with known prior exposure because:
- Prior maternal CMV infection does not preclude congenital infection, as reactivation or reinfection can occur 3, 5
- However, the risk of severe fetal sequelae is significantly lower with non-primary (secondary) infection compared to primary infection 4
- The absence of effective preventive interventions for asymptomatic women limits the clinical utility of universal screening 3
Important Caveats About CMV Serology Interpretation
Critical Limitations of CMV IgM Testing
A negative CMV IgM in the second trimester does NOT exclude congenital CMV infection 6. This is a common clinical pitfall:
- CMV IgM may be negative even when congenital infection is present, particularly if maternal infection occurred in the first trimester 6
- CMV IgM has poor positive predictive value (only 16.4%) in asymptomatic pregnant women undergoing routine screening 7
- False-positive CMV IgM results are common and can lead to unnecessary anxiety and interventions 7, 8
Essential Follow-Up When CMV IgM is Positive
If CMV IgM is positive, IgG avidity testing must be performed to distinguish primary from non-primary infection 1, 3:
- Low IgG avidity + positive IgM = suggests primary infection (higher risk to fetus)
- High IgG avidity + positive IgM = suggests non-primary infection or false-positive IgM (lower risk)
- IgG avidity testing is essential regardless of clinical setting and should be included in the diagnostic algorithm 7
Special Populations Requiring Consideration
Seronegative healthcare and childcare workers may be offered serologic monitoring during pregnancy, and monitoring may be considered for seronegative pregnant women with young children in daycare 4. However, this is distinct from testing women with known prior exposure.
When Fetal Testing Should Be Pursued
If primary CMV infection is confirmed (IgM positive with low IgG avidity or documented seroconversion), amniocentesis for CMV PCR should be considered, performed at least 6-8 weeks after maternal infection and after 21 weeks of gestation 1, 3, 4.